{"id":68357,"date":"2024-11-19T21:04:00","date_gmt":"2024-11-19T19:04:00","guid":{"rendered":"https:\/\/gulftech-news.com\/en\/?p=68357"},"modified":"2024-11-20T09:14:01","modified_gmt":"2024-11-20T07:14:01","slug":"oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia","status":"publish","type":"post","link":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/","title":{"rendered":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia"},"content":{"rendered":"\n

Seoul, & Riyadh; Gulf Tech News<\/strong><\/p>\n\n\n\n

OncoMASTER, a Korea-based leader in precision oncology, and NOVO Genomics, a pioneering Saudi biotech company, have signed a Memorandum of Understanding (MOU) to launch several advanced feasibility studies in personalized cancer treatment for Saudi patients. This collaboration represents a significant step in harnessing AI-driven oncology insights to bring precision medicine to the Middle East and positions Saudi Arabia as a regional leader in advanced cancer care.<\/p>\n\n\n\n

“We at NOVO Genomics are thrilled to partner with OncoMASTER, bringing their transformative AI technology to Saudi Arabia.<\/p>\n\n\n\n

This collaboration will allow us to improve cancer care outcomes and establish the Kingdom as a leader in precision oncology,\u201d said Abdulelah Alhawsawi, CEO of NOVO Genomics. \u201cThis MOU represents a significant step forward for our mission to deliver world-class healthcare solutions aligned with Saudi Vision 2030.<\/p>\n\n\n\n

This MOU reflects a pivotal collaboration in precision oncology, with both OncoMASTER and NOVO Genomics dedicated to advancing healthcare through innovation.<\/p>\n\n\n\n

 By integrating OncoMASTER\u2019s predictive models with NOVO Genomics\u2019 local genomic expertise, the partnership aims to bring personalized cancer treatment options to Saudi patients and enhance clinical trial accessibility in the region.<\/p>\n\n\n\n

This MOU not only strengthens Saudi Arabia\u2019s leadership role in precision oncology but also paves the way for skill development in AI and genomics, potentially creating high-value jobs and contributing to a robust biotech ecosystem.<\/p>\n\n\n\n

\u201cWe are excited to partner with NOVO Genomics and to bring the potential of OncoMASTER\u2019s AI-driven oncology models to Saudi Arabia.<\/p>\n\n\n\n

 This collaboration will not only help improve patient outcomes but could also serve as a framework for broader precision medicine applications in the Middle East,\u201d said Dr. Woo Young Jang, CEO of OncoMASTER.<\/p>\n\n\n\n

Through this strategic MOU, OncoMASTER and NOVO Genomics will explore multiple collaborative initiatives to bring data-driven oncology solutions to Saudi Arabia, including:<\/p>\n\n\n\n

    \n
  1. implement and evaluate OncoMASTER\u2019s predictive AI model, which classifies colorectal cancer patients into treatment groups likely to benefit from specific therapies;<\/li>\n\n\n\n
  2. feasibility study on an AI-based clinical trial matching solution, ultimately improving patient access to cutting-edge treatments; and<\/li>\n\n\n\n
  3. collaboration on OncoMASTER’s other AI-driven solutions, designed to enhance precision oncology capabilities by integrating genomic and clinical data, paving the way for further personalization in cancer treatment.<\/li>\n<\/ol>\n\n\n\n

    Inspired by the success of South Korea\u2019s K-MASTER, the MOU includes discussions on establishing the “S-MASTER” project\u2014Saudi Arabia\u2019s version of the K-MASTER initiative. The S-MASTER project aims to create one of the region\u2019s largest cancer genomics databases, specifically tailored to the genetic profiles of Saudi patients. This initiative would support innovative cancer therapies and personalized treatment options in Saudi Arabia, driving forward Saudi Vision 2030\u2019s goal of a world-class healthcare system.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Seoul, & Riyadh; Gulf Tech News OncoMASTER, a Korea-based leader in precision oncology, and NOVO Genomics, a pioneering Saudi biotech company, have signed a Memorandum of Understanding (MOU) to launch several advanced feasibility studies in personalized cancer treatment for Saudi patients. This collaboration represents a significant step in harnessing AI-driven oncology insights to bring precision …<\/p>\n","protected":false},"author":1,"featured_media":68360,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[642],"tags":[970],"class_list":["post-68357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tie-business","tag-oncomaster-and-novo-genomics"],"yoast_head":"\nOncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News\" \/>\n<meta property=\"og:description\" content=\"Seoul, & Riyadh; Gulf Tech News OncoMASTER, a Korea-based leader in precision oncology, and NOVO Genomics, a pioneering Saudi biotech company, have signed a Memorandum of Understanding (MOU) to launch several advanced feasibility studies in personalized cancer treatment for Saudi patients. This collaboration represents a significant step in harnessing AI-driven oncology insights to bring precision …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/\" \/>\n<meta property=\"og:site_name\" content=\"Gulf Tech News\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-19T19:04:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-20T07:14:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/\",\"url\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/\",\"name\":\"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News\",\"isPartOf\":{\"@id\":\"https:\/\/gulftech-news.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447\",\"datePublished\":\"2024-11-19T19:04:00+00:00\",\"dateModified\":\"2024-11-20T07:14:01+00:00\",\"author\":{\"@id\":\"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/fe4fb4a528850de8e0c9209ece797e29\"},\"breadcrumb\":{\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage\",\"url\":\"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447\",\"contentUrl\":\"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447\",\"width\":1200,\"height\":900,\"caption\":\"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gulftech-news.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gulftech-news.com\/en\/#website\",\"url\":\"https:\/\/gulftech-news.com\/en\/\",\"name\":\"Gulf Tech News\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gulftech-news.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/fe4fb4a528850de8e0c9209ece797e29\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3d0f856a1e2ecd3d5d413e0d92ad06cc1e8a8204ee82b45b90080aea490467d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3d0f856a1e2ecd3d5d413e0d92ad06cc1e8a8204ee82b45b90080aea490467d8?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"sameAs\":[\"https:\/\/gulftech-news.com\/en\"],\"url\":\"https:\/\/gulftech-news.com\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/","og_locale":"en_US","og_type":"article","og_title":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News","og_description":"Seoul, & Riyadh; Gulf Tech News OncoMASTER, a Korea-based leader in precision oncology, and NOVO Genomics, a pioneering Saudi biotech company, have signed a Memorandum of Understanding (MOU) to launch several advanced feasibility studies in personalized cancer treatment for Saudi patients. This collaboration represents a significant step in harnessing AI-driven oncology insights to bring precision …","og_url":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/","og_site_name":"Gulf Tech News","article_published_time":"2024-11-19T19:04:00+00:00","article_modified_time":"2024-11-20T07:14:01+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447","type":"image\/jpeg"}],"author":"Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/","url":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/","name":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia - Gulf Tech News","isPartOf":{"@id":"https:\/\/gulftech-news.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage"},"image":{"@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage"},"thumbnailUrl":"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447","datePublished":"2024-11-19T19:04:00+00:00","dateModified":"2024-11-20T07:14:01+00:00","author":{"@id":"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/fe4fb4a528850de8e0c9209ece797e29"},"breadcrumb":{"@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#primaryimage","url":"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447","contentUrl":"https:\/\/gulftech-news.com\/en\/wp-content\/uploads\/2024\/11\/From-right-to-left-Dr-Woo-Young-Jang-CEO-Oncomaster-and-Abdulelah-Alhawsawi-CEO-NOVO-Genomics-sign-a-MoU-at-the-Launchpad-Pilot-Roadshow-2024.-2.jpg?v=1732086447","width":1200,"height":900,"caption":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia"},{"@type":"BreadcrumbList","@id":"https:\/\/gulftech-news.com\/en\/2024\/11\/19\/oncomaster-and-novo-genomics-sign-mou-for-groundbreaking-precision-oncology-feasibility-studies-in-saudi-arabia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gulftech-news.com\/en\/"},{"@type":"ListItem","position":2,"name":"OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia"}]},{"@type":"WebSite","@id":"https:\/\/gulftech-news.com\/en\/#website","url":"https:\/\/gulftech-news.com\/en\/","name":"Gulf Tech News","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gulftech-news.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/fe4fb4a528850de8e0c9209ece797e29","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gulftech-news.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3d0f856a1e2ecd3d5d413e0d92ad06cc1e8a8204ee82b45b90080aea490467d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3d0f856a1e2ecd3d5d413e0d92ad06cc1e8a8204ee82b45b90080aea490467d8?s=96&d=mm&r=g","caption":"Admin"},"sameAs":["https:\/\/gulftech-news.com\/en"],"url":"https:\/\/gulftech-news.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/posts\/68357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/comments?post=68357"}],"version-history":[{"count":1,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/posts\/68357\/revisions"}],"predecessor-version":[{"id":68361,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/posts\/68357\/revisions\/68361"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/media\/68360"}],"wp:attachment":[{"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/media?parent=68357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/categories?post=68357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gulftech-news.com\/en\/wp-json\/wp\/v2\/tags?post=68357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}